Brilliance is a blue LED-based phototherapy unit which provides radiation to treat hyperbilirubinaemia in infants. Brilliance was developed by D-REV, a not-for-profit organization, in Palo Alto, California, with partners including the Stanford School of Medicine. Brilliance meets the standards of the American Academy of Pediatrics for effective jaundice treatment.
Cool blue light
Brilliance is highly effective at breaking down bilirubin. The radiation emitted by Brilliance is free of IR and UV radiation, having a wavelength range of 430–490 nanometres, with the peak located between 445 and 465 nanometres.
The peak spectral intensity of the light is >40 μW/cm2/nm.
The radiation from the bank of LEDs is focused downward, to the baby. There is minimal scatter of the light into the care-provider space.
Benchtop [Benchmark?] tests were conducted on Brilliance and two other LED phototherapy units at the Neonatal and Developmental Medicine Laboratory at Stanford University. Brilliance clearly had the most even and intense footprint among the three models.
Long life, maintenance-free
LEDs have a much longer life compared with ordinary tube lights and CFLs. Brilliance’s LEDs produce radiation effectively for 50,000 hours. Replacement of LEDs is not required for years!
Brilliance is an extremely cost-effective solution. It is priced much lower than comaparable products.
Baby- and mother-friendly
Brilliance is compatible with most other hospital equipment. It may be used to provide phototherapy to the infant in any bed, incubator or warmer. It can also be used to provide treatment when the baby is being nursed, so that mother and child need not be separated for phototherapy.
The base slides out of the way under the bed or other equipment.
Brilliance features a machine run time totalizer. A therapy time totalizer to manage the baby’s radiation therapy is optional.